SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Korn JH, LeRoy EC. The immunopathogenesis of systemic sclerosis: introduction. Int Rev Immunol 1995; 12: iv.
  • 2
    Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma. Arthritis Rheum 1992; 35: 6772.
  • 3
    Hasegawa M, Fujimoto M, Kikuki K, Takehara K. Elevated serum levels of interleukin-4 (IL-4), IL-10 and IL-13 in patients with systemic sclerosis. J Rheumatol 1997; 24: 32832.
  • 4
    Postlethwaite AE. Role of T cells and cytokines in effecting fibrosis. Int Rev Immunol 1995; 12: 24758.
  • 5
    Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, et al. Animal model of sclerotic skin. I. Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999; 112: 45662.
  • 6
    Gillery P, Fertin C, Nicolas JF, Chastang F, Kalis B, Bachereau J, et al. Interleukin-4 stimulates collagen gene expression in human fibroblasts. FEBS Lett 1992; 302: 2314.
  • 7
    Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992; 90: 147985.
  • 8
    Wegrowsky Y, Paltot V, Gillery P, Kalis B, Randoux A, Marquart FX. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant interleukin-4. J Biochem 1995; 307: 6739.
  • 9
    Oriente A, Fedarko NS, Paccocha SE, Huang A-K, Lichtenstein LM, Essayan DM. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharm Exp Ther 2000; 292: 98894.
  • 10
    Salmon-Ehr V, Serpier H, Nawrocki B, Gillery PH, Clavel C, Kalis B, et al. Expression of interleukin-4 in scleroderma skin specimens in fibroblast culture. Arch Dermatol 1996; 132: 8026.
  • 11
    Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in NOD mice. J Exp Med 1999; 184: 10939.
  • 12
    Elbe-Burger A, Egyed A, Olt S, Klubal R, Mann U, Rappersberger K, et al. Overexpression of IL-4 alters homeostasis in the skin. J Invest Dematol 2002; 118: 76778.
  • 13
    Ong C, Wong C, Roberts CR, Teh HS, Jirik FR. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma. Eur J Immunol 1998; 28: 261929.
  • 14
    Ong CJ, Ip S, Teh S-J, Wong C, Jirik FR, Grusby MJ, et al. A role for helper cells in mediating skin fibrosis in tight-skin mice. Cell Immunol 1999; 196: 608.
  • 15
    Kodera T, McGaha TL, Phelps R, Paul WE, Bona CA. Disrupting the IL-4 gene rescues mice homozygous for tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts. Proc Natl Acad Sci U S A 2002; 99: 38005.
  • 16
    McGaha T, Saito S, Phelps RG, Gordon R, Noben-Trauth N, Paul WE, et al. Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4Rα and transforming growth factor-β genes. J Invest Dermatol 2001; 116: 13643.
  • 17
    Keegan AD, Nelms K, Wang L-M, Pierce JH, Paul WE. Interleukin-4 receptor: signaling mechanisms. Immunol Today 1994; 15: 42332.
  • 18
    Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, et al. Essential role of Stat6 in IL-4 signaling. Nature 1996; 380: 62730.
  • 19
    Murata T, Husain SR, Mohri H, Puri RJ. Two different IL-13 chains are expressed in normal skin fibroblasts and IL-4 and IL-13 mediate signal transduction through a common pathway. Int Immunol 1998; 10: 110310.
  • 20
    Paul WE. IL-4, a multifunctional regulator of immunity and inflammation. J Cancer Res 1991; 82: 14589.
  • 21
    Doucet C, Jasmin C, Azzarone B. Unusual interleukin-4 and 13 signaling in human normal and tumor lung fibroblasts. Oncogene 2000; 19: 5896905.
  • 22
    McGaha TL, Kodera T, Spiera H, Stan AC, Pines M, Bona CA. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun–dependent mechanism. Arthritis Rheum 2002; 46: 274861.
  • 23
    Bona C. Genetic defects in tight skin mice developing a scleroderma-like syndrome. Curr Dir Autoimmun 1999; 1: 194207.
  • 24
    Funk WD, Pack DT, Karas RH, Wright WE, Shay JW. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 1992; 12: 286671.
  • 25
    Chomarat P, Bachereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998; 17: 152.
  • 26
    Hitraya EG, Varga J, Arlett CM, Jiménez SA. Identification of elements in the promoter region of α1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. Arthritis Rheum 1998; 41: 204858.
  • 27
    Vergeer WP, Sogo JM, Pretorius PJ, de Vries WN. Interaction of Ap1, Ap2, and Sp1 with the regulatory regions of the human pro-α1(I) collagen gene. Arch Biochem Biophys 2000; 377: 6979.
  • 28
    Ingaki A, Truter S, Ramirez F. TGFβ stimulates α2(I) collagen production through cis-acting element that contains Sp-1 binding site. J Biol Chem 1994; 269: 1482834.
  • 29
    Philips N, Bashey R, Jimenez SA. Increased α1(I) procollagen gene expression in tight skin (TSK) mice myocardial fibroblasts is due to a reduced interaction of negative regulatory sequence with AP-1 transcription factor. J Biol Chem 1995; 270: 931321.
  • 30
    Atamas SP, Luzina IG, Dai H, Wilt SG, White B. Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J Immunol 2002; 168: 113940.
  • 31
    Zang W, Ou J, Inagaki Y, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor β1 stimulation of α2(I) collagen (COL1A2) transcription. J Biol Chem 2000; 275: 3923745.
  • 32
    Gingras S, Simard J, Groner B, Pfitzner E. p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res 1999; 27: 27229.
  • 33
    Shiraski F, Makhluf HA, LeRoy EC, Watson DK, Trojanowska M. Ets transcription factors cooperate with Sp1 to activate human tenascin-C promoter. Oncogene 1999; 18: 775564.
  • 34
    Chung K-Y, Agarwal A, Uitto J, Mauviel A. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen promoter activity by transforming growth factor-β. J Biol Chem 1996; 272: 32728.
  • 35
    Chen CH, Stavnezer J. Activation of the mouse Ig germline epsilon promoter by IL-4 is dependent on AP-1 transcription factors. J Immunol 2001; 166: 41123.